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Abstract
LASEK and PRK are common laser corrective eye procedures that aim to correct the refractive
errors of the eye, although these procedures do carry the potential of post-operation complications
of dry eye and symptoms of pain and photophobia as a result of corneal innervation damage.
Resveratrol was tested on the surface of the cornea to see if the drug would be effective at
attenuating post-corrective eye pain. Male and female rats underwent a unilateral corneal abrasion
surgery that aimed to mimic the post-op symptoms of PRK. The rats either received the resveratrol
drug treatment or a vehicle formulation. The Rat Grimace Scale was used to measure spontaneous
pain by grading the severity of orbital tightening, where a higher orbital tightening score represents a
higher value of pain. Results showed that there was no significant difference between resveratrol and
the vehicle formulation on orbital tightening. There was however a differential response to
resveratrol between males and females. Male orbital tightening scores were significantly higher than
females, most apparent at 72 hours and 1-week post-abrasion. Histological analysis of the β‐Tubulin
and CGRP in the cornea was also performed to examine the volume of corneal nerves and their
peptide content. The histological assessment did not show a significant difference in β‐Tubulin and
CGRP levels between the vehicle and resveratrol groups. The findings of this study does not
provide support for the use of resveratrol as a post-corrective eye surgery therapeutic.

Introduction
As an alternative to eyeglasses or contact lenses, many patients that suffer from refractive errors of
the eye elect to undergo laser corrective eye surgery. Becoming increasingly popular for patients who
are not viable candidates for LASIK are procedures such as photorefractive keratectomy (PRK) and
laser-assisted sub-epithelial keratectomy (LASEK). Both of these procedures involve the removal of
the corneal epithelium with alcohol to access the underlying corneal stromal tissue for ablation with
excimer lasers. A consequence of these operations is the potential development of dry eye and
associated symptoms of pain, irritation, and photophobia (Herrmann et al, 2015). Ocular pain is
mediated by corneal epithelial nerve endings that have their cell bodies in the trigeminal ganglion.
Persistent pain may emerge as a result of spontaneous neural activity from the interaction of the
abnormally regenerated epithelial nerves with adjacent nerve endings (Ebrahimiadib et al., 2020). In
some cases, these acute conditions could become permanent conditions such as with chronic dry
eye. Patients that develop chronic dry eye disease exhibit reduced tear secretion which can lead to
inflammation and peripheral nerve damage. Inflammation has been shown to increase sensitization
of pain sensory neurons (hyperalgesia), and if inflammation were to persist it can lead to changes of
gene expression at the trigeminal ganglion effecting their excitability and firing (Belmonte et al.
2017).

Current treatment for post-operative pain consists of usage of non-steroidal anti-inflammatory drugs
(NSAIDs) and opioids, although the efficacy of these drugs have been called to question. Treatment
with NSAIDs carries side effects of gastric distress, while the use of opioids carries high risk for
addiction. Currently there are opportunities in the pharmaceutical field for the development of new

therapeutic treatments that are both beneficial in alleviating symptoms, while also limiting potential
harmful side effects.

Prior research has shown the benefits of the drug, resveratrol on the healing process. In mice hind
paw incision models, the drug has shown to be able to reduce acute pain without impairing wound
healing (Dasgupta and Milbrandt, 2007) and additionally, it was able to prevent the transition into
the chronic pain state (Tillu et al., 2012; Burton et al, 2017). Resveratrol, a polyphenol that originates
from plant sources is an activator of the enzyme AMP-activated protein kinase (AMPK) which
modulates excitability of peripheral nociceptors. Activation of AMPK leads to suppression of
proteins such as rapamycin (mTOR) and kinases like mitogen activated protein kinase pathways
(MAPK) which are important for sensitization and pain development (Tillu et al., 2012). As a
potentially viable treatment in reducing acute spontaneous pain, the effectiveness of resveratrol was
tested in a rodent model of PRK.

Methods:
Subjects and Experimental Design
Rats underwent a corneal abrasion surgery (Hegarty et al, 2018) where heptanol was used to remove
the corneal epithelium from the left eye. The procedure aimed to mimic the effects of corrective eye
surgery by producing acute pain, as well as chronic dry eye symptoms. Three different
concentrations of resveratrol were tested in different groups of rats (1%, 2%, 4%) and final testing
used a 4% concentration of the drug. Resveratrol emulsion was applied to the ocular surface 24
hours prior to surgery, 10 minutes after surgery, and 24 hours after surgery - a timeframe that is

feasible for human ocular surgeries. This study utilized both male and female rats, tested and graded
under the same conditions to ensure that the effects of resveratrol are consistent in both sexes. In
addition to the treatment groups, this study employed a control group that received no corneal
abrasion and treatment on the eye, and a vehicle group where the rats underwent corneal abrasion
surgery, but received a vehicle emulsion on the eye rather than resveratrol.

Behavioral Assessments
To evaluate spontaneous pain after corneal abrasion, the Rat Grimace Scale (Sotocinal et al. 2011)
was used which rates the severity of behavioral pain through the displayed degree of orbital
tightening (OT). The grading scale ranges from 0-2 where 0 represents no tightening, 1 is moderate,
and 2 is obvious and clear orbital tightening. Each of the rats were graded at baseline prior to
surgery and treatment, as well as at additional time points post-operation to evaluate for changes in
pain.

Histological Assessments
Immunohistochemical analysis of corneal tissue was performed to examine changes in corneal
innervation, as well as peptide content within the nerve fibers. Antibodies against β-Tubulin and
Calcitonin gene-related peptide (CGRP) were used for these studies. β‐Tubulin is a microtubule that
help make up the structure and morphology of neurons. Within the β‐Tubulin family are three
classes: Class I (TUBB1), Class II (TUBB2), and Class III (TUBB3) that are strongly expressed in
neurons (Niwa et al, 2013). Since β‐Tubulin plays a vital role in the compositional structure of
neurons, it is expected that β‐Tubulin levels will decrease after neuronal injury. CGRP is a

neuropeptide whose expression has been seen to be upregulated after the occurrence of peripheral
nerve injury. The continuous expression of CGRP has been associated with nerve regeneration
(Chen et al. 2010).

Control and experimental rats were perfused with 4% paraformaldehyde and corneas were dissected
and placed in 0.1 M phosphate buffer (PB), pH 7.4 until immunoprocessing. Corneas were rinsed in
0.1 M PB and 0.1 M Tris-buffered saline (TS), pH 7.6, blocked in 0.1% bovine serum albumin,
0.25% Triton-X in TS and then incubated for 3 nights at 4°C in a cocktail of primary antibodies
raised against β-tubulin and CGRP. Corneas were then rinsed and incubated in a cocktail of
secondary antibodies conjugated with fluorophores for 2 hours at room temperature. The
fluorescent-labeled markers of interest were visualized using a Zeiss LSM 900 confocal microscope.
The resultant confocal scans were then analyzed using Bitplane Imaris software where the corneal
epithelium was traced and volume of β-tubulin-labeled nerves and CGRP-labeled nerves were
measured.

Results
Differences in orbital tightening scores between males vs. females when treated with resveratrol
We found that there was an increase in OT at 24 hours’ after corneal abrasion compared to baseline
in both the vehicle and treatment groups (Figure 1A & 1B) which is consistent with the expectation
that corneal injury evokes acute pain, but also shows that the drug did not reduce acute nociceptive
responses. The subsequent grading periods showed a contrast between the resveratrol-treated male
and female groups in regards to how OT scores changed over time. In the female group, it was

observed that when rats were treated with resveratrol there is a greater decrease in OT when
compared to the vehicle. For female rats treated with resveratrol, at 72 hours, OT values were
significantly lower than at 24 hours (p<0.05), and were comparable to OT scores at the one-week
mark in the vehicle group. At the one-week time point for resveratrol treated female rats, OT scores
were similar to baseline (pre-injury) values.

Within the male groups, rats that received the vehicle formulation displayed a similar pattern of OT
scores over time to their female vehicle counterparts. However, in resveratrol treated male rats, the
OT scores stayed consistently higher than the vehicle treated rats. From 24 – 72 hours, OT scores in
the male resveratrol treated group stayed approximately at the same value, followed by a minor
decrease at the one-week mark.

A two-way repeated measures ANOVA with Holm-Sidak post-hoc comparisons did not show a
significant difference for vehicle vs. resveratrol in either male or female groups. Whereas a two-way
repeated measures ANOVA conducted between the resveratrol groups of male vs. female revealed a
significant level of difference at 72 hours and 1-week post-operation where at these time periods,
male groups showed significantly higher OT scores in comparison to females (p<.001) (Figure 1C).
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Figure 1: Effect of resveratrol on OT scores over time (A) OT scores for treatment vs. vehicle in
male rats (n = 4 Vehicle; 4 Resveratrol) (* p < 0.05 vs. Baseline; # p < 0.05 vs 1 week). (B) OT
scores for treatment vs. vehicle in female rats (n = 4 Vehicle; 3 Resveratrol.) (* p < 0.05 vs. Baseline;
# p < 0.05 vs 1 week; ^ p < 0.05 vs 24 hours) (C) Comparison of male vs. female treatment groups
results from figure 1A and 1B. A two-way repeated measures ANOVA with Holm-Sidak and
pairwise multiple comparison post hoc test was used to determine differences between treatment
groups. There was no effect of treatment group (Vehicle vs Resveratrol) in either the male or female
groups. There were significant differences between males vs. females at 72 hours and 1 week
(

p < 0.001.)

Immunohistochemistry
We examined corneal tissues at 1-week post-abrasion in vehicle and resveratrol-treated rats, as well
as control animals that received no surgery and no eye treatment. The corneal tissue analysis showed
that in female rats, the %β‐Tubulin volume at 1-week post-abrasion showed a decrease in both the
vehicle and resveratrol group when compared to the control (p<0.05) (Figure 2A). The male group
also showed lower values of %β‐Tubulin volume in the vehicle and resveratrol groups, although the
reduction in nerve density was less pronounced than the female group. For both male and female
groups, a t-test showed no significant differences between vehicle and resveratrol.

The volume of CGRP within the β‐Tubulin volume for each animal was examined (Figure 2C, D).
%CGRP volume of the female group showed a significant decrease in the vehicle and resveratrol
groups vs. the control (p<0.05) (Figure 2C). In comparison, the male group showed no significant
change in CGRP volume when treated with the vehicle or resveratrol when compared to the control.
(Figure 2D). A t-test showed that there were no significant differences between vehicle vs.
resveratrol in either male and female groups.

A two-way ANOVA was used to examine if there were any differences in β‐Tubulin or CGRP when
comparing the male drug vs. female drug groups. For the %β‐Tubulin, no interaction was found
between sex vs treatment. As for %CGRP volume, a two-way ANOVA was attempted but
normality and equal variance tests both failed, likely due to the high variance in the male drug group.
These findings show that corneal abrasion caused a loss of nerve fibers that was still present one

week later in females, and resveratrol treatment did not cause any changes in the loss of corneal
nerves.
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Figure 2: Levels of β‐Tubulin and CGRP volume % measured at 1-week post-abrasion. (A)
β‐Tubulin nerve density for female rats (* p < 0.05 vs. Control). (B) β‐Tubulin nerve density for
male rats (C) CGRP for female rats (* p < 0.05 vs. Control) (D) CGRP for male rats. A t-test or
Mann-Whitney Rank Sum test was used to compare resveratrol vs. vehicle for each group. There
were no significant differences between vehicle and resveratrol for any metric. A sex vs. treatment
two-way ANOVA was attempted for β‐Tubulin and CGRP, respectively. β‐Tubulin volume showed
no interaction between sex vs treatment, while normality and equal variance tests both failed in the
CGRP test.

Discussion:
Refractive eye surgeries such as PRK and LASEK have become increasingly popular for patients.
These surgeries involve the removal of the corneal epithelium which can lead to the development of
post-op conditions of pain, discomfort, and photophobia. Prior studies have shown that resveratrol
is effective in mice hind paw incision models in limiting acute pain and development in the chronic
pain state (Dasgupta and Milbrandt, 2007; Tillu et al., 2012). Seeing resveratrol’s usefulness, we
wished to see similar results when resveratrol is used on the eye after an abrasion surgery.

The behavioral results were ultimately disappointing. The usage of resveratrol on the eye did not
show an improvement of acute pain, and as for the attenuation of pain over time, there did not seem
to be a difference when compared to the vehicle groups. Furthermore, it would be advisory for
males to limit the use of resveratrol not only because there does not appear to be a noticeable
benefit, but the drug could be harmful as it can amplify the duration of pain. Deviations from the
results of prior studies could be from differential activation of various pain pathways in the eye in
comparison to other areas of the body. Whether the AMPK pathway and associated downstream
proteins and kinases (Tillu et al., 2012) are still involved, or if there are other processes at play could
be a topic of further study. The effect of resveratrol on pain pathways could also explain the
differences in sex response as proteins associated with the transmission of pain are upregulated
rather than suppressed in males, explaining the increased OT scores. Another plausible explanation
is that the amount of uptake of the resveratrol emulsion into the eye could also have affected the
results. It is possible that the mechanism of drug uptake in male and female rats could have resulted
in greater or less absorption of the drug.

This study utilized the Rat Grimace Scale (Sotocinal et al. 2011) as a means of measuring behavioral
displays of spontaneous pain. The application of this grading scale does have some merits. The first
being its main grading criteria, orbital tightening, is applicable towards actual human behavior. Postop, many human patients display similar eye squinting activity as a result of photophobia. Secondly,
this grading model is able to limit the need for excess handling and harm for the rats in comparison
to other methods that focus on evoked pain.

The histological analysis displayed a reduction of β‐Tubulin nerve density and CGRP peptide in
non-control groups, although there wasn’t a substantial change in the regeneration of nerve density
or difference in CGRP count when resveratrol was used. Data analysis was used to see if the
histological data could provide a link to the sex difference seen in the behavioral data. The tests
though did not appear to show an effect of sex on treatment.

Overall, taking into account behavioral and histological assessments, the data does not provide a
compelling argument for the usage of resveratrol on the cornea. While the usage of resveratrol has
been shown to provide beneficial healing effects in prior studies, the extension of its usage to the
cornea cannot be recommended. Research on other compounds that could be helpful as a
therapeutic for post-corrective eye surgery pain is still worthwhile. Compounds such as vitamin D
may play an important role for in modulating corneal wound healing (Reins et al, 2016), and could
be a worthwhile compound to further examine.
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